Table 2 Health impact assessment for PM2.5 (all-natural causes, lung cancer, ALRI, COPD).
Study year | ||||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
Mortality, All (Natural) Causes (adults age 30 + Years) | ||||||
Estimated Attributable Proportion | 19.93% (15.49–22.03%) | 20.19% (15.69–22.31%) | 15.44% (11.92–17.12%) | 18.42% (14.28–20.38%) | 18% (13.95–19.92%) | 20.7% (16.1-22.87%) |
Estimated number of Attributable Cases | 2093 (1627–2314) | 2513 (1954–2778) | 1810 (1398–2007) | 2213 (1716–2449) | 2208 (1711–2444) | 2750 (2139–3038) |
Estimated number of Attributable Cases per 100,000 Population at Risk | 134.93 (104.86-149.17) | 145.92 (113.44-161.29) | 102.50 (79.17-113.67) | 120.65 (93.56-133.52) | 118.09 (91.52-130.72) | 143.19 (111.40-158.21) |
RR (Lower-Upper) | 1.249 (1.183–1.283) | 1.253 (1.186–1.287) | 1.183 (1.135–1.207) | 1.226 (1.167–1.256) | 1.219 (1.162–1.249) | 1.261 (1.192–1.296) |
Mortality, LC (25 + years old) | ||||||
Estimated Attributable Proportion | 21.78% (15.6-27.63%) | 21.95% (15.75–27.81%) | 18.51% (12.64–24.11%) | 20.75% (14.6-26.48%) | 20.45% (14.33–26.16%) | 22.29% (16.04–28.18%) |
Estimated number of Attributable Cases | 46 (33–59) | 50 (36–63) | 37 (25–48) | 49 (34–62) | 41 (29–53) | 48 (34–61) |
Estimated number of Attributable Cases per 100,000 Population at Risk | 2.34 (1.68–2.97) | 2.40 (1.72–3.03) | 1.75 (1.19–2.27) | 2.25 (1.58–2.87) | 1.91 (1.34–2.44) | 2.18 (1.57–2.76) |
RR (Lower-Upper) | 1.279 (1.185–1.382) | 1.281 (1.187–1.385) | 1.227 (1.145–1.317) | 1.262 (1.171–1.360) | 1.257 (1.167–1.354) | 1.287 (1.191–1.392) |
Mortality, ALRI for children (0–5 years) | ||||||
Estimated Attributable Proportion | 17.46% (10.21–25.71%) | 17.64% (10.34–25.94%) | 14.07% (7.83–21.61%) | 16.34% (9.4-24.37%) | 16.02% (9.18-24%) | 18.01% (10.61–26.39%) |
Estimated number of Attributable Cases | 2 (1–3) | 1 (1–2) | 1 (1–2) | 7 (4–10) | 2 (1–4) | 7 (4–11) |
Estimated number of Attributable Cases per 100,000 Population at Risk | 0.49 (0.29–0.73) | 0.34 (0.20–0.51) | 0.30 (0.16–0.45) | 1.71 (0.99–2.55) | 0.65 (0.37–0.97) | 2.17 (1.28–3.18) |
RR (Lower-Upper) | 1.211 (1.114–1.346) | 1.214 (1.115–1.350) | 1.164 (1.085–1.276) | 1.195 (1.104–1.322) | 1.191 (1.101–1.316) | 1.219 (1.119–1.359) |
Mortality, COPD for adults (25 + years) | ||||||
Estimated Attributable Proportion | 22.49% (16.42–28.27%) | 22.71% (16.61–28.51%) | 18.38% (12.93–23.72%) | 21.14% (15.29–26.82%) | 20.76% (14.96–26.41%) | 23.15% (16.97–28.98%) |
Estimated number of Attributable Cases | 49 (36–61) | 65 (47–81) | 75 (53–97) | 120 (87–153) | 49 (35–62) | 68 (50–85) |
Estimated number of Attributable Cases per 100,000 Population at Risk | 2.47 (1.81–3.11) | 3.09 (2.26–3.87) | 3.55 (2.50–4.59) | 5.58 (4.03–7.08) | 2.26 (1.63–2.88) | 3.10 (2.27–3.88) |
RR (Lower-Upper) | 1.290 (1.196–1.394) | 1.294 (1.199–1.399) | 1.225 (1.148–1.311) | 1.268 (1.180–1.367) | 1.262 (1.176–1.359) | 1.301 (1.204–1.408) |